4/A

PRIMARY DOCUMENT

Company: FILANA THERAPEUTICS, INC.
Filed: May 6, 2010
Period of Report: May 3, 2010
Accession Number: 0001245261-10-000019

View Document ↗ View on SEC.gov ↗